{"id":"https://openalex.org/W2139588002","doi":"https://doi.org/10.1093/jnci/86.24.1846","title":"Growth and Chemotherapeutic Response of Cells in a Hollow-Fiber In Vitro Solid Tumor Model","display_name":"Growth and Chemotherapeutic Response of Cells in a Hollow-Fiber In Vitro Solid Tumor Model","alternate_titles":[],"publication_year":1994,"publication_date":"1994-12-21","ids":{"openalex":"https://openalex.org/W2139588002","doi":"https://doi.org/10.1093/jnci/86.24.1846","mag":"2139588002","pmid":"https://pubmed.ncbi.nlm.nih.gov/7990159"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/86.24.1846","doi":"https://doi.org/10.1093/jnci/86.24.1846","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/86.24.1846","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139588002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031668078","display_name":"Joseph J Casciari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J. J. Casciari","raw_affiliation_strings":["Developmental Therapeutics Program, National Cancer Institute, Bethesda, Md 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, National Cancer Institute, Bethesda, Md 20892","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080778766","display_name":"Melinda G. Hollingshead","orcid":"https://orcid.org/0000-0002-1207-1397","observed_orcids":["https://orcid.org/0000-0002-1207-1397"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. G. Hollingshead","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036347756","display_name":"Michael C. Alley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. C. Alley","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037320524","display_name":"Joseph G. Mayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. G. Mayo","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041180857","display_name":"Louis Malspeis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Malspeis","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Cancer Institute-Frederick Cancer Research and Development Center Frederick, Md","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Miyauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Miyauchi","raw_affiliation_strings":["Department of Biophysical Chemistry. Faculty of Pharmaceutical Sciences, Hokkaido University Sapporo, Japan","Hokkaido University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biophysical Chemistry. Faculty of Pharmaceutical Sciences, Hokkaido University Sapporo, Japan","institution_ids":["https://openalex.org/I205349734"]},{"raw_affiliation_string":"Hokkaido University","institution_ids":["https://openalex.org/I205349734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051619378","display_name":"Michael R. Grever","orcid":"https://orcid.org/0000-0002-1605-7875","observed_orcids":["https://orcid.org/0000-0002-1605-7875"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. R. Grever","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute Bethesda, Md","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute Bethesda, Md","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026079862","display_name":"John N. Weinstein","orcid":"https://orcid.org/0000-0001-9401-6908","observed_orcids":["https://orcid.org/0000-0001-9401-6908"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. N. Weinstein","raw_affiliation_strings":["Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute Bethesda, Md","Bioinformatics & Computational Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute Bethesda, Md","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Bioinformatics & Computational Biology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5031668078"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":0.7356,"has_fulltext":false,"cited_by_count":90,"citation_normalized_percentile":{"value":0.72185215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"86","issue":"24","first_page":"1846","last_page":"1852"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.060100000351667404,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin-sensitivity","display_name":"doxorubicin sensitivity","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6489999890327454},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.5979999899864197},{"id":"https://openalex.org/keywords/drug-dose-response","display_name":"drug dose-response","score":0.6230000257492065},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.5720000267028809},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6491984128952026},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.4446497857570648},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37575390934944153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21973422169685364},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13271385431289673}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001672","descriptor_name":"Biocompatible Materials","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003124","descriptor_name":"Colorimetry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014410","descriptor_name":"Tumor Stem Cell Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/86.24.1846","doi":"https://doi.org/10.1093/jnci/86.24.1846","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/86.24.1846","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:7990159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7990159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.899.8877","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.899.8877","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/86/24/1846.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2434105553","https://openalex.org/W2197311287","https://openalex.org/W1527375643","https://openalex.org/W2316527789","https://openalex.org/W2131002009","https://openalex.org/W2883320419","https://openalex.org/W1990450805","https://openalex.org/W2054863378","https://openalex.org/W2406463267"],"abstract_inverted_index":{"BACKGROUND:":[0],"Cancer":[1],"treatments":[2],"that":[3,25],"appear":[4],"promising":[5],"in":[6,13,16,27,88,107,154,172,203,219,269,286,294],"tissue":[7],"culture":[8],"are":[9,36],"often":[10],"less":[11],"effective":[12],"solid":[14,54,311,323],"tumors,":[15,167],"part":[17],"because":[18],"of":[19,70,142,159,174,182,237,240,281,292,308],"the":[20,68,133,143,224,229,234,265,274,290,306,309],"proliferative":[21],"and":[22,48,72,97,116,161,243,251,289],"microenvironmental":[23],"heterogeneity":[24],"develops":[26],"these":[28],"tumors":[29,156,250,324],"as":[30,314],"they":[31],"grow.":[32],"Heterogeneous":[33],"tumor":[34,55,78,84,145,217,282,312],"models":[35],"thus":[37],"needed":[38],"for":[39,50,87,191,248,317,328],"drug":[40,51,225,258,296,330],"screening.":[41],"PURPOSE:":[42],"Our":[43],"goal":[44],"was":[45,120,129,261],"to":[46,131,150,210,284],"develop":[47],"test":[49],"evaluation":[52],"a":[53,75,211,300,315],"model":[56,313],"based":[57,125],"on":[58,67,126],"cell":[59,85,137,146,170,186],"growth":[60,90,280],"inside":[61,91],"biocompatible":[62],"hollow":[63,108,204,287],"fibers.":[64],"METHODS:":[65],"Building":[66],"experience":[69],"Hollingshead":[71],"co-workers":[73],"with":[74,157,271,299],"sparse-cell,":[76],"hollow-fiber":[77,166,249,310],"model,":[79],"we":[80],"tested":[81,148],"six":[82],"human":[83,144],"lines":[86,147],"vitro":[89,155,295],"450-microns":[92],"internal-diameter":[93],"polyvinylidine":[94],"fluoride":[95],"fibers":[96,109,205,288],"examined":[98,112],"them":[99],"histologically.":[100],"Human":[101],"SW620":[102,165],"colon":[103],"carcinoma":[104],"cells":[105,202,218,283],"grown":[106],"were":[110,177,206,216,246,268],"also":[111],"using":[113],"electron":[114],"microscopy,":[115],"their":[117],"doxorubicin":[118,213],"sensitivity":[119],"assessed.":[121],"A":[122],"colorimetric":[123,266,303],"assay":[124,267,304],"sulforhodamine":[127],"B":[128],"adopted":[130],"replace":[132],"more":[134,208],"cumbersome":[135],"clonogenic":[136,275],"survival":[138],"assay.":[139,276],"RESULTS:":[140],"Five":[141],"grew":[149],"confluence,":[151],"forming":[152],"heterogeneous":[153],"subpopulations":[158],"viable":[160,169,185],"necrotic":[162],"cells.":[163],"For":[164],"maximum":[168],"populations":[171],"excess":[173],"10(8)":[175],"cells/mL":[176],"obtained":[178,247],"after":[179],"8":[180],"days":[181],"growth.":[183],"This":[184],"density":[187],"remained":[188],"roughly":[189],"constant":[190],"3-4":[192],"days,":[193],"permitting":[194],"dose-response":[195,297],"experiments":[196,298],"over":[197],"this":[198],"time":[199,260],"interval.":[200],"Tumor":[201],"much":[207],"resistant":[209],"4-hour":[212],"exposure":[214,259],"than":[215],"monolayers:":[220],"LC50":[221,254],"values":[222,255],"(i.e.,":[223],"concentrations":[226],"at":[227],"which":[228],"plating":[230,235],"efficiency":[231,236],"equals":[232],"one-half":[233],"untreated":[238],"cells)":[239],"3.5":[241],"microM":[242,245],"0.16":[244],"monolayers,":[252],"respectively.":[253],"decreased":[256],"when":[257],"increased.":[262],"Results":[263],"from":[264,273],"agreement":[270],"those":[272],"CONCLUSION:":[277],"The":[278],"successful":[279],"confluence":[285],"feasibility":[291],"performing":[293],"relatively":[301],"easy":[302],"demonstrate":[305],"potential":[307],"tool":[316],"experimental":[318,329],"therapeutic":[319],"research.":[320],"IMPLICATION:":[321],"Hollow-fiber":[322],"may":[325],"prove":[326],"useful":[327],"evaluation.":[331]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139588002","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
